Strategic growth NYOH operates eight cancer centers across the Capital Region with a patient-centric model and expanding specialty services, presenting cross-sell opportunities for affiliated technologies, imaging, and ancillary care partnerships.

Clinical talent With a team of 35 board-certified physicians and over 300 cancer care specialists, there is potential to introduce advanced medical devices, diagnostic tools, or clinical trial enablement partnerships to augment care delivery and research programs.

Recent hires New specialty oncology physicians joined in late 2025, signaling momentum in gynecologic oncology and breast cancer care—potential entry points for targeted equipment, imaging services, and pharmacologic partnerships.

Tech integration Current tech stack includes Epic Systems and other digital tools; opportunities exist to propose interoperable software, data analytics, and patient engagement solutions that integrate with existing workflows and EHRs.

Revenue health Estimated revenue in the $50M–$100M range with multiple centers indicates a scalable customer for high-value products, services, and programs such as equipment upgrades, remote monitoring, and service contracts.